NatureCell Co.Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.00%

NatureCell Co.Ltd (007390) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of NatureCell Co.Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

₩-60.00

≈ $-0.04 USD Cash + Short-term Investments

Total Assets

₩71.32 Billion

≈ $48.33 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how NatureCell Co.Ltd's Asset Resilience Ratio has changed over time. See NatureCell Co.Ltd (007390) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down NatureCell Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NatureCell Co.Ltd (007390) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩-60.00	-0.0%
Total Liquid Assets	₩-60.00	0.00%

Asset Resilience Insights

Limited Liquidity: NatureCell Co.Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

NatureCell Co.Ltd Industry Peers by Asset Resilience Ratio

Compare NatureCell Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Theragen Etex Co.Ltd KQ:066700	Pharmaceuticals	1.52%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%
Kolon Life Science Inc KQ:102940	Pharmaceuticals	1.22%

Annual Asset Resilience Ratio for NatureCell Co.Ltd (2009–2024)

The table below shows the annual Asset Resilience Ratio data for NatureCell Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	39.40%	₩28.37 Billion ≈ $19.23 Million	₩72.00 Billion ≈ $48.79 Million	-4.27pp
2023-12-31	43.67%	₩29.87 Billion ≈ $20.24 Million	₩68.40 Billion ≈ $46.35 Million	+10.43pp
2022-12-31	33.24%	₩31.26 Billion ≈ $21.18 Million	₩94.02 Billion ≈ $63.72 Million	-13.49pp
2021-12-31	46.73%	₩32.55 Billion ≈ $22.06 Million	₩69.65 Billion ≈ $47.20 Million	-9.82pp
2020-12-31	56.56%	₩48.50 Billion ≈ $32.87 Million	₩85.75 Billion ≈ $58.11 Million	+6.86pp
2019-12-31	49.70%	₩46.28 Billion ≈ $31.36 Million	₩93.11 Billion ≈ $63.10 Million	+21.58pp
2018-12-31	28.12%	₩14.87 Billion ≈ $10.07 Million	₩52.88 Billion ≈ $35.83 Million	+9.95pp
2017-12-31	18.16%	₩9.34 Billion ≈ $6.33 Million	₩51.44 Billion ≈ $34.86 Million	+11.61pp
2016-12-31	6.55%	₩3.45 Billion ≈ $2.34 Million	₩52.67 Billion ≈ $35.69 Million	+6.43pp
2015-12-31	0.12%	₩57.04 Million ≈ $38.66K	₩45.97 Billion ≈ $31.15 Million	-0.29pp
2014-12-31	0.41%	₩100.40 Million ≈ $68.04K	₩24.54 Billion ≈ $16.63 Million	-5.70pp
2010-12-31	6.11%	₩1.39 Billion ≈ $939.29K	₩22.70 Billion ≈ $15.38 Million	-10.08pp
2009-12-31	16.18%	₩4.63 Billion ≈ $3.13 Million	₩28.58 Billion ≈ $19.37 Million	--

pp = percentage points

About NatureCell Co.Ltd

KQ:007390 Korea Pharmaceuticals

Market Cap

$688.81 Million

₩1.02 Trillion KRW

Market Cap Rank

#10928 Global

#325 in Korea

Share Price

₩19150.00

Change (1 day)

-3.38%

52-Week Range

₩16900.00 - ₩37800.00

All Time High

₩58126.80